Pharmafocus presents a round-up of developments in the contract research sector, including Icon's acquisition of biomarker specialist Veeda, layoffs at …
Ofichem acquires US drug substance CDMO Kinentia
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine

